Brief: KOLINPHARMA H1 Net Result Turns To Profit Of EUR 0.4 Mln, Sees 2024 Revenue Between EUR 18-20 Mln
Sept 29 (Reuters) - Kolinpharma SpA KIP.MI :
* REPORTED ON TUESDAY H1 NET PROFIT EUR 0.4 MLN VS LOSS EUR
0.1
MLN YEAR AGO
* UPDATES 2021 ESTIMATES, SEES SALES IN RANGE OF EUR
10.5-11.5
MILLION, EBITDA MARGIN IN LINE WITH H1 RESULTS
* APPROVES 2021-2024 BUSINESS PLAN
* TARGETS 2024 REVENUE IN RANGE OF EUR 18-20 MLN
Further company coverage: KIP.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kolinpharma SpA
See all newsBrief: Igea Holding Crosses 95% Of Kolinpharma In Context Of Takeover Bid
Brief: Kolinpharma Shareholder PRP Sells About 59.62% Of Share Capital To Igea Holding
Brief: Igea Holding Buys Additional 0.927% Of Kolinpharma Share Capital
Brief: Takeup In Takeover Bid By Igea Holding On Kolinpharma Reaches 59.411% Of Shares To Which Offer Relates
Brief: Igea Holding Buys 4.9% Of Kolinpharma Share Capital, Surpasses 90% Treshold